Jan G.P. Thijssen

Showing 1-20 of 25 articles

Coronary interventions

Bioresorbable vascular scaffold versus Xience metallic stents: outcomes in the AIDA trial stratified by SYNTAX score

Kraak R, Tijssen RY, van Dongen I, Elias J, Hofma S, van der Schaaf R, Arkenbout E, Weevers A, Thijssen J, Piek J, de Winter R, Henriques J, Wykrzykowska J

May 7, 2019 | 10.4244/EIJ-D-18-00884

Coronary interventions

Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: Insights from the randomized GLOBAL LEADERS trial

Serruys P, Tomaniak M, Chichareon P, Modolo R, Kogame N, Takahashi K, Chang C, Spitzer E, Walsh S, Adlam D, Hildick-Smith D, Edes I, van der Harst P, Krackhardt F, Thijssen J, Rademaker-Havinga T, Garg S, Steg P, Hamm C, Jüni P, Vranckx P, Onuma Y, Verheugt F

March 17, 2019 | 10.4244/EIJ-D-19-00202

Clinical outcomes after percutaneous coronary intervention with the COMBO stent versus Resolute Integrity and PROMUS Element stents: a propensity-matched analysis

Kalkman D, Kok MM, van der Heijden LC, Woudstra P, Beijk M, Thijssen J, von Birgelen C, de Winter R

November 20, 2017 | 10.4244/EIJ-D-17-00301

Coronary interventions

Clinical outcomes with the STENTYS self-apposing coronary stent in patients presenting with ST-segment elevation myocardial infarction: two-year insights from the APPOSITION III (A Post-Market registry to assess the STENTYS self-exPanding COronary Stent In AcuTe MyocardIal InfarctiON) registry

Lu H, Grundeken M.J, Vos N, IJsselmuiden A, van Geuns R, Wessely R, Dengler T, La Manna A, Silvain J, Montalescot G, Spaargaren R, Thijssen J, Amoroso G, de Winter R, Koch K

August 4, 2017 | 10.4244/EIJ-D-16-00676

Coronary interventions

Does acute coronary syndrome impact on the incidence of thrombosis after the implantation of an Absorb bioresorbable vascular scaffold?

Sotomi Y, Miyazaki Y, Collet C, Asano T, Suwannasom P, Thijssen J, de Winter R, Waksman R, Lipinski M, Onuma Y, Serruys P

March 20, 2017 | 10.4244/EIJ-D-16-00472

Coronary interventions

Two-year clinical outcomes of Absorb bioresorbable vascular scaffold implantation in complex coronary artery disease patients stratified by SYNTAX score and ABSORB II study enrolment criteria

Kraak R, Grundeken M.J, Hassell M, Elias J, Koch K, Henriques J, Piek J, Baan Jr J, Vis M, Thijssen J, de Winter R, Wykrzykowska J

August 5, 2016 | 10.4244/EIJV12I5A95

Coronary interventions

Basal stenosis resistance index derived from simultaneous pressure and flow velocity measurements

van de Hoef T, Petraco R, van Lavieren M, Nijjer S, Nolte F, Sen S, Echavarría-Pinto M, Henriques J, Koch K, Baan Jr J, de Winter R, Siebes M, Spaan J, Thijssen J, Meuwissen M, Escaned J, Davies J, Piek J

June 10, 2016 | 10.4244/EIJV12I2A33

Coronary interventions

First-in-man evaluation of the novel balloon delivery system STENTYS Xposition S for the self-apposing coronary artery stent: impact on longitudinal geographic miss during stenting

Lu H, IJsselmuiden A, Grundeken M.J, Nassif M, de Vries A, Weevers A, Scholte M, Spaargaren R, Wykrzykowska J, Thijssen J, de Winter R, Koch K

March 18, 2016 | 10.4244/EIJY15M05_07

Head-to-head comparison of basal stenosis resistance index, instantaneous wave-free ratio, and fractional flow reserve: diagnostic accuracy for stenosis-specific myocardial ischaemia

van de Hoef T, Meuwissen M, Escaned J, Sen S, Petraco R, van Lavieren M, Echavarría-Pinto M, Nolte F, Nijjer S, Chamuleau SAJ, Voskuil M, van Eck-Smit B, Verberne H, Henriques J, Koch K, de Winter R, Spaan J, Siebes M, Thijssen J, Davies J, Piek J

December 20, 2015 | 10.4244/EIJY14M08_17

Treatment of coronary bifurcation lesions with the Absorb bioresorbable vascular scaffold in combination with the Tryton dedicated coronary bifurcation stent: evaluation using two- and three-dimensional optical coherence tomography

Grundeken M.J, Hassell M, Kraak R, de Bruin D, Koch K, Henriques J, van Leeuwen T, Thijssen J, Piek J, de Winter R, Wykrzykowska J

December 20, 2015 | 10.4244/EIJY14M08_15

Pressure-controlled intermittent coronary sinus occlusion (PICSO) in acute ST-segment elevation myocardial infarction: results of the Prepare RAMSES safety and feasibility study

van de Hoef T, Nijveldt R, van der Ent M, Neunteufl T, Meuwissen M, Khattab A, Berger R, Kuijt W, Wykrzykowska J, Thijssen J, van Rossum A, Stone G, Piek J

May 19, 2015 | 10.4244/EIJY15M03_10

Three-year clinical outcome in the Primary Stenting of Totally Occluded Native Coronary Arteries III (PRISON III) trial: a randomised comparison between sirolimus-eluting stent implantation and zotarolimus-eluting stent implantation for the treatment of total coronary occlusions

Teeuwen K, Van den Branden B, Koolen J, van der Schaaf R, Henriques J, Thijssen J, Kelder J, Vermeersch P, Rensing B, Suttorp MJ

March 20, 2015 | 10.4244/EIJY14M08_07

Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry

Kraak R, Hassell M, Grundeken M.J, Koch K, Henriques J, Piek J, Baan Jr J, Vis M, Arkenbout E, Thijssen J, de Winter R, Wykrzykowska J

February 20, 2015 | 10.4244/EIJY14M08_08

Long-term mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in patients with insulin-treated versus non-insulin-treated diabetes mellitus

Hoebers L, Claessen B, Woudstra P, De Vries J, Wykrzykowska J, Vis M, Baan Jr J, Koch K, Thijssen J, de Winter R, Piek J, Henriques J

May 20, 2014 | 10.4244/EIJV10I1A15

Increased hyperaemic coronary microvascular resistance adds to the presence of myocardial ischaemia

Nolte F, van de Hoef T, Meuwissen M, Voskuil M, Chamuleau SAJ, Henriques J, Verberne H, van Eck-Smit B, Koch K, de Winter R, Spaan J, Thijssen J, Siebes M, Piek J

April 22, 2014 | 10.4244/EIJV9I12A240

Primary Stenting of Totally Occluded Native Coronary Arteries III (PRISON III): a randomised comparison of sirolimus-eluting stent implantation with zotarolimus-eluting stent implantation for the treatment of total coronary occlusions

Van den Branden B, Teeuwen K, Koolen J, van der Schaaf R, Henriques J, Thijssen J, Kelder J, Vermeersch P, Rensing B, Suttorp MJ

November 29, 2013 | 10.4244/EIJV9I7A138

Six-month and one-year clinical outcomes after placement of a dedicated coronary bifurcation stent: a patient-level pooled analysis of eight registry studies

Grundeken M.J, Asgedom S, Damman P, Lesiak M, Norell M, Garcia E, Bethencourt A, Woudstra P, Koch K, Vis M, Henriques J, Onuma Y, Foley DP, Bartorelli A, Stella P, Thijssen J, de Winter R, Wykrzykowska J

June 28, 2013 | 10.4244/EIJV9I2A34

Late catch-up in lumen diameter at five-year angiography in MACE-free patients treated with sirolimus-eluting stents in the Primary Stenting of Totally Occluded Native Coronary Arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II)

Teeuwen K, Van den Branden B, Rahel B, Laarman G, Thijssen J, Kelder J, Slagboom T, ten Berg J, Suttorp MJ

June 28, 2013 | 10.4244/EIJV9I2A36

Acute haemodynamic effects of accelerated idioventricular rhythm in primary percutaneous coronary intervention

Delewi R, Remmelink M, Meuwissen M, van Royen N, Vis M, Koch K, Henriques J, de Winter R, Thijssen J, Baan Jr J, Piek J

August 30, 2011 | 10.4244/EIJV7I4A76

Clinical results after coronary stenting with the GenousTM Bio-engineered R stentTM: 12-month outcomes of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry

Silber S, Damman P, Klomp M, Beijk M, Grisold M, Ribeiro E, Suryapranata H, Wójcik J, Sim K, Thijssen J, de Winter R

February 21, 2011

Latest news

New issue

TAVR in sarcopaenia; CCTA or TEE in LAAC; Iintravascular lithotripsy, read the new issue

(CT scans of a sarcopaenic patient)

October 18, 2019

Free access

Medical device regulation in Europe – what is changing and how can I become more involved?

October 18, 2019

Free Access

New this week: Insights from an International CTO Registry

October 22, 2019

Free access

Guidelines, consensus & position papers

April 9, 2019

Editorial

When is it best to stop aspirin and who could ultimately benefit?

Aspirin-free antiplatelet regimens after PCI

October 9, 2019

Free access

The EuroIntervention health check 2019

October 4, 2019

Free Access

Last week's JAA: Hydrodynamic function with the ALLEGRA heart valve

October 15, 2019

Jan G.P. Thijssen

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke